MiRNA-124 regulates the sensitivity of renal cancer cells to cisplatin-induced necroptosis by targeting the CAPN4-CNOT3 axis

BACKGROUND: Currently, drug-resistance is a major challenge in the treatment of renal cancer. Although microRNAs (miRNAs) have been reported to contribute to the incidence of drug resistance in renal cancer, the bio-functional roles and underlying regulatory mechanisms of novel miRNAs in cisplatin r...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Qingyan, Zhuang, Qianfeng, Shen, Jie, Chen, Zhen, Xue, Dong, Ding, Tao, He, Xiaozhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511534/
https://www.ncbi.nlm.nih.gov/pubmed/34733662
http://dx.doi.org/10.21037/tau-21-777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511534/
https://www.ncbi.nlm.nih.gov/pubmed/34733662
http://dx.doi.org/10.21037/tau-21-777

Ejemplares similares